Sloan Sheldon — SEC Form 4 filings
SEC reporting owner CIK 2038798. 7 Form 4 filings on record with FilingPulse; latest filed 2026-07-02.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-10-01 to 2026-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 11 legs across 4 filings — 102,958 shares, $7,354,472 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 21,306 shares @ $69.53 ($1,481,406) in Spyre Therapeutics, Inc., filed 2026-05-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | Chief Medical Officer | 7 | — | 11 legs · 102,958 sh · $7,354,472 | 11 |
Form 4 filings — Sloan Sheldon
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-02 | 4 | Spyre Therapeutics, Inc. (SYRE) | Option exercise (M): 8,334 @ $27.46 · Sale (S): 6,500 @ $87.52 · Sale (S): 1,834 @ $88.34 · Option exercise (M): 8,334 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Spyre Therapeutics, Inc. (SYRE) | Option exercise (M): 8,333 @ $27.46 · Sale (S): 8,333 @ $75 · Option exercise (M): 8,333 (derivative) @ $0 | EDGAR |
| 2026-05-01 | 4 | Spyre Therapeutics, Inc. (SYRE) | Option exercise (M): 78,333 @ $27.46 · Sale (S): 21,306 @ $69.53 · Sale (S): 19,656 @ $70.61 · Sale (S): 8,777 @ $71.56 · Sale (S): 12,777 @ $72.94 · Sale (S): 10,358 @ $73.74 · +3 more | EDGAR |
| 2026-04-03 | 4 | Spyre Therapeutics, Inc. (SYRE) | Option exercise (M): 7,958 @ $21.66 · Sale (S): 7,958 @ $50 · Option exercise (M): 7,958 (derivative) @ $0 | EDGAR |
| 2026-01-13 | 4 | Spyre Therapeutics, Inc. (SYRE) | Grant/award (A): 140,000 (derivative) @ $0 | EDGAR |
| 2025-01-17 | 4 | Spyre Therapeutics, Inc. (SYRE) | Grant/award (A): 95,500 (derivative) @ $0 | EDGAR |
| 2024-10-01 | 4 | Spyre Therapeutics, Inc. (SYRE) | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2038798 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →